Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9bd593d3-5e9c-471c-adb9-7f2c09bed1ae&Preview=1 Date 12/18/2008 Company Name 3Tier Environmental Forecast Group Mailing Address 2001 Sixth Avenue Seattle, WA 98121 Company Description 3TIER is an energy efficiency company: we provide the core data and knowledge for clients to make the best decisions regarding their investment in a renewable energy generation technology. 3TIER is unique in … Continue reading “3Tier Environmental Forecast Group Receives $10,000,000 New Funding Round”
Ex-Entellium Execs Plead Guilty to Fraud
Seattle-based Entellium’s former CFO, Parrish Jones, pled guilty to one count of wire fraud in U.S. District Court today, as reported by the Seattle Times and TechFlash. Jones faces 33 to 41 months in prison for his alleged role in falsifying company revenues. Last week, Entellium’s former CEO Paul Johnston also pled guilty to fraud, … Continue reading “Ex-Entellium Execs Plead Guilty to Fraud”
Vampires, Smartphones, and Social Activism: Which Websites Were Hot in 2008
It’s not just Facebook, MySpace, and Wikipedia anymore. A large number of social websites and wikis have become major players on the Web. Today’s launch of the Seattle-based cooking site Foodista.com is the latest example. But the top social sites of the year were dedicated to TV shows, social activism, gaming, smartphones, and education—in that … Continue reading “Vampires, Smartphones, and Social Activism: Which Websites Were Hot in 2008”
Foodista Unveils Social Cooking Site
Seattle-based Foodista has opened up a cooking website that everyone can edit, wiki-style. Billed as an online cooking encyclopedia, the site includes information on food, recipes, techniques, and tools, and allows users to share their knowledge by posting comments, editing content, and uploading photos. The site is run by former Amazon veterans Barnaby Dorfman and … Continue reading “Foodista Unveils Social Cooking Site”
Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study
San Diego-based Cadence Pharmaceuticals shares shot up about 30 percent this morning after the company announced it had success in a clinical trial with a new version of an old pain reliever. Cadence (NASDAQ: [[ticker:CADX]]) says its version of acetaminophen, the pain reliever marketed in tablets by Johnson & Johnson as Tylenol, succeeded in a … Continue reading “Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study”
SellMyTimeshareNow Raises $8.5M
Sell My Timeshare Now, the Dover, NH-based operator of timeshare resale and rental Web site SellMyTimeshareNow.com, says it has raised $8.5 million in expansion capital. The company says that Edison Venture Fund, which has offices in Needham, MA and elsewhere, is the company’s only institutional investor.
Xconomy, Seattle Post-Intelligencer Form Partnership to Share Online News, Features
Xconomy’s growing audience in the Seattle area just got even bigger. Today, my colleague Greg Huang and I are thrilled to announce that our company has formed a partnership with one of the heavyweights of the Northwest news business, the Seattle Post-Intelligencer. Under this deal, the P-I readers will get access to Xconomy news and … Continue reading “Xconomy, Seattle Post-Intelligencer Form Partnership to Share Online News, Features”
Venture Survey Forecasts A Big Chill, With Solar Bright Spot, in 2009
More gloomy forecasts from private investors in high-tech sectors. U.S. venture capitalists see a cooling trend in the investment climate for the year ahead. One of the only bright spots I saw in the National Venture Capital Association (NVCA) Predictions Survey is that a majority of VCs are optimistic that the market for initial public … Continue reading “Venture Survey Forecasts A Big Chill, With Solar Bright Spot, in 2009”
Yale Endowment Down 25 Percent
Yale University president Richard Levin revealed in this letter yesterday that the New Haven, CT, university’s endowment was valued at an estimated $17 billion, down an about 25 percent from June 30, 2008. The letter follows Harvard University’s announcement earlier this month that its endowment lost more than $8 billion, or 22 percent, of its … Continue reading “Yale Endowment Down 25 Percent”
Abbott Labs Acquires Isis Diagnostics Unit for $215M
Good news for shareholders of Carlsbad, CA-based Isis Pharmaceuticals. Abbott Laboratories, the diversified health products giant, is exercising its right to acquire Isis’ diagnostics spinoff, Ibis Biosciences, for a total of $215 million plus some future payments tied to sales of the instruments. Abbott Park, IL-based Abbott (NYSE: [[ticker:ABT]]) will pay Isis shareholders $175 million … Continue reading “Abbott Labs Acquires Isis Diagnostics Unit for $215M”
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
New England’s life sciences firms got a lot of news from the FDA this past week—not all of it good. Here’s more on that, and the rest of the week’s news from the sector. —Ryan caught up with the CEO of Targanta Therapeutics (NASDAQ:[[ticker:TARG]]) the day after the FDA has decided to not to approve … Continue reading “Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News”
Lilly’s San Diego Biotechnology Center of Silence
Eli Lilly and Co. executives were downright chatty about the company’s biotechnology strategy last week when they convened a meeting with Wall Street analysts. “We see more and more that biotech is a key to sustaining pharmaceutical innovation for the future,” Lilly’s vice president of biotech discovery research, Tom Bumol, said in a statement the … Continue reading “Lilly’s San Diego Biotechnology Center of Silence”
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity
VLST has nailed down its first partnership with a major pharmaceutical company. The Seattle biotech is announcing today it has formed an exclusive, worldwide collaboration that will allow Danish drugmaker Novo Nordisk to develop drugs against cell targets VLST has discovered for autoimmune and inflammatory diseases. It’s a pretty big deal for VLST. The collaboration … Continue reading “VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity”
ITA Software: The Travel Company Everyone Uses and No One Knows Reinvents Airline Reservations, Again
In the heart of Cambridge, MA, a few blocks from the MIT campus and across the street from the missile-guidance labs at Draper Laboratories, there’s a 10-story brick office building with a brand-new corporate logo near its crown. It’s the ITA Software building, and the LED-backed logo, with its distinctive airplane-tailed @ sign, was switched … Continue reading “ITA Software: The Travel Company Everyone Uses and No One Knows Reinvents Airline Reservations, Again”
Will Biomass Power the Utilities of the Near Future?
Oil prices have recently dropped well below $100 in response to slower economic growth around the world. But this decline doesn’t necessarily mean that the utilities industry will be able to provide cheaper power to millions of American consumers and companies. In fact, utilities are going to face huge and upward price pressure on the … Continue reading “Will Biomass Power the Utilities of the Near Future?”
Seattle-Area Wireless Companies (and Others) Look to Innovate, Expand in China
A couple of news tidbits involving China in the past week have made me look more closely at what local startups and companies are doing to expand there. On Thursday, Seattle-based Airbiquity, a wireless communications firm focused on the auto industry, announced it has entered the Chinese market, branding itself locally as Ai Bi Ke … Continue reading “Seattle-Area Wireless Companies (and Others) Look to Innovate, Expand in China”
Seventh Sense Biosystems Raises $4.75M Series A, Board Attracts MIT’s Langer and Other Big Names
Cambridge, MA-based Flagship Ventures has managed to keep the existence of one of the companies it has been incubating, Seventh Sense Biosystems, a secret for about a year. But the closing of the startup’s Series A round of financing put some information about the firm in the public domain this week. (PE Hub had this … Continue reading “Seventh Sense Biosystems Raises $4.75M Series A, Board Attracts MIT’s Langer and Other Big Names”
SellMyTimeshareNOW Obtains $8,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da51aec8-2012-4b50-9c86-2fa373b12b71&Preview=1 Date 12/17/2008 Company Name SellMyTimeshareNOW Mailing Address 383 Central Ave Dover, NH 03820 Company Description Sell My Timeshare NOW is the global leader in connecting timeshare buyers, sellers, and renters! Our Expert Staff intimately understands what it takes to make the rental or sale of a timeshare quick and hassle free. … Continue reading “SellMyTimeshareNOW Obtains $8,500,000 New Financing Round”
ExaGrid Systems Obtains $12,000,000 Series D Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=89813037-54ce-4900-aba1-371defb06bca&Preview=1 Date 12/17/2008 Company Name ExaGrid Systems Mailing Address 2000 West Park Drive Westborough, MA 01581 Company Description ExaGrid Systems, an innovator in Self-Protecting Storage, provides the industry’s most comprehensive integrated storage and data protection solutions. Website http://www.exagrid.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction Round Series D Proceeds Purposes Proceeds … Continue reading “ExaGrid Systems Obtains $12,000,000 Series D Funding Round”
CalciMedica Secures $4,000,000 of $12,000,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c77dd3f1-f597-4ac0-8e48-5103070f11a2&Preview=1 Date 11/21/2008 Company Name CalciMedica Mailing Address 505 Coast Blvd S. La Jolla, CA 92037 Company Description The company is developing drugs focused on autoimmune and inflammatory diseases. Website http://www.calcimedica.com Transaction Type Venture Equity Transaction Amount $4,000,000 Transaction Round Series C Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “CalciMedica Secures $4,000,000 of $12,000,000 Series C Funding”
Pixim Obtains $13,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8a8086f-f180-48dc-a068-4eadc1a8566f&Preview=1 Date 12/17/2008 Company Name Pixim Mailing Address 1395 Charleston Rd. Mountain View, CA 94043 Company Description Pixim Inc. has developed an imaging platform that produces substantially higher-quality moving and still images than those available through any other existing technology. Website http://www.pixim.com Transaction Type Venture Equity Transaction Amount $13,000,000 Transaction Round Undisclosed … Continue reading “Pixim Obtains $13,000,000 New Funding Round”
Tela Innovations Lands $5,500,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=68308855-52a0-4066-9749-5a7a7dd60106&Preview=1 Date 12/17/2008 Company Name Tela Innovations Mailing Address 655 Campbell Technology Parkway Campbell, CA 95008-5061 Company Description Tela Innovations offers a next-generation solution for designing advanced semiconductors in the ‘sub wavelength,’ low k 1 era – 45nm and beyond. The Tela solution uses on-grid, straight line, one dimensional layout structures to … Continue reading “Tela Innovations Lands $5,500,000 Series C Round”
Tagged Receives $5,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5b6308c4-996e-4192-a1b4-6aa49b49a115&Preview=1 Date 12/17/2008 Company Name Tagged Mailing Address 110 Pacific Ave Mall Box #117 San Francisco, CA 94111 Company Description The company operates a social networking destination for teenagers. Website http://www.tagged.com Transaction Type Debt Transaction Amount $5,000,000 Transaction Round Undisclosed Proceeds Purposes The additional funds will enable us to continue to support … Continue reading “Tagged Receives $5,000,000 New Financing Round”
Chegg Secures $25,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=583c9b1f-c801-4170-a9f3-db6855db20fe&Preview=1 Date 12/17/2008 Company Name Chegg Mailing Address 4655 Old Ironsides Road Santa Clara, CA 95054 Company Description Chegg, whose name is a combination of “chicken” and “egg,” was conceived out of the founders’ frustration with the used book-buying policies at their university bookstore – which would pay students a fraction of … Continue reading “Chegg Secures $25,000,000 Series C Round”
India’s Innovation Front Lines, Part 4: Of Hyper-Competition and Corruption
Bangalore, December 15—For 45 years after independence, Indian companies for all practical purposes operated without competition. Monopolies were granted by the government for extended periods. Many fortunes were made, both by industrialists and corrupt politicians. Consumers had to wait years for “luxury” goods such as cars and telephones. This began to change in 1992, when … Continue reading “India’s Innovation Front Lines, Part 4: Of Hyper-Competition and Corruption”
Amgen’s Bid to Make Cancer Drug “Personalized” Lacks Data, FDA Panel Says
Amgen, the world’s largest biotechnology company, with operations in Seattle and Cambridge, MA, came up short in its bid to make its colorectal cancer drug personalized today in front of a panel of expert advisers to the FDA. The panel said Amgen and Eli Lilly will have to run more clinical trials to gather enough … Continue reading “Amgen’s Bid to Make Cancer Drug “Personalized” Lacks Data, FDA Panel Says”
State Tobacco Cash Funneled Into Vaccines, Biotech Drug Delivery, Cardiac Arrest, and Mental Health Research
(Update: This story has added information on the six finalists that fell short in their bid for state grants.) Washington’s Life Sciences Discovery Fund just made a bunch of biomedical researchers either very happy, or highly disappointed. The 10-year, $350 million initiative, which takes money from the state tobacco settlement, chose to pump almost $19 … Continue reading “State Tobacco Cash Funneled Into Vaccines, Biotech Drug Delivery, Cardiac Arrest, and Mental Health Research”
Mass Life Sciences Center Attracts J&J Matching Funds, Awards $3.7M in Industry-Academic Grants
It’s a big day for the Massachusetts Life Sciences Center, the quasi-public agency that manages the state’s plan to invest $1 billion in its life sciences industry over the next 10 years. New Jersey-based medical products giant Johnson & Johnson (NYSE:[[ticker:JNJ]]) has become the first company to join the agency’s new Corporate Consortium intended to … Continue reading “Mass Life Sciences Center Attracts J&J Matching Funds, Awards $3.7M in Industry-Academic Grants”
PressOK, Movaya Team Up for Mobile Games
Seattle-based Movaya and PressOK Entertainment announced today they are joining forces to develop mobile games. Financial terms and impact of the deal were not disclosed. PressOK was formed by the merger of mobile-gaming companies Reaxion and Mobliss in September. Reaxion’s development teams are in Russia and Belarus, while Movaya’s team is in China.
Axeda Buys Questra
Foxborough, MA-based Axeda announced today that it has acquired Questra of Redwood City, CA. Both companies make software-as-a-service systems that allow software administrators to remotely upgrade and service enterprise IT systems and software. The terms of the acquisition were not published.
SAIC Gets Biofuels R&D Contract
It turns out that DARPA, the Pentagon’s R&D funding agency, awarded two biofuel development contracts last week, and both went to San Diego companies. As we reported, the Defense Advanced Research Projects Agency awarded a $19.5 million contract to a consortium headed by General Atomics. Yesterday, the Pentagon said DARPA also awarded a $14.9 million … Continue reading “SAIC Gets Biofuels R&D Contract”
EMC Appoints Leader for Decho, Cloud Services
Storage giant EMC (NYSC: [[ticker:EMC]]) of Hopkinton, MA, said today that veteran software executive Harel Kodesh has been appointed president of the company’s Cloud Infrastructure division and CEO of Decho, a new subsidiary formed in November from the combination of EMC’s Mozy and Pi divisions. Kodesh is the former chief products officer at Missouri-based telecommunications … Continue reading “EMC Appoints Leader for Decho, Cloud Services”
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation
It’s cold outside, so I was a little bummed there was no actual fire at an event last night billed as a “fireside chat.” This get-together actually took some time to warm up (pun intended). But once it got rolling, three of the most experienced life sciences entrepreneurs in the region shed some light on … Continue reading “Luck, Curiosity, Naivete: The Essential Ingredients of Innovation”
Arch Names Two New Partners
Arch Venture Partners, which has its Northwest offices in Seattle, says that it has named Kristina Burow and Paul Thurk as partners. Burow is a co-founder and director of Seattle-based domestic crude oil firm Sapphire Energy and is based at Arch’s San Francisco office. Thurk, who began his career in the firm’s Austin office, co-founded … Continue reading “Arch Names Two New Partners”
Legislator Drafting Bill to Outlaw Non-Compete Agreements in Massachusetts
Many Massachusetts companies require new employees to sign agreements saying that if they leave, they won’t go to work for a competitor for at least a year. The idea behind these non-compete agreements is to prevent a company’s competitors from gaining access to trade secrets and key personnel. But there’s a growing chorus of entrepreneurs, … Continue reading “Legislator Drafting Bill to Outlaw Non-Compete Agreements in Massachusetts”
ATV Promotes Energy Leader Friendly
Waltham, MA-based Advanced Technology Ventures has promoted New England clean energy maven Andrew Friendly to principal, the firm announced today. Friendly co-heads the Renewable Energy Business Network and serves on the New England Clean Energy Council’s advisory board. He also represents ATV on the boards of AltaRock Energy and Solar Junction. His promotion came as … Continue reading “ATV Promotes Energy Leader Friendly”
$2.6M Helps Healionics Heal, Uptake Takes In $3M, BlueKai Gets $10.5M Boost, & More Seattle-Area Deals News
Maybe it’s because everyone is trying to get their deals announced before the holidays, but it was a busy week in the Northwest, with plenty of activity in mobile software, online media, and medical devices. —Bellevue, WA-based BlueKai, an Internet marketing firm, raised $10.5 million in Series B funding, led by Waltham, MA-based Battery Ventures. … Continue reading “$2.6M Helps Healionics Heal, Uptake Takes In $3M, BlueKai Gets $10.5M Boost, & More Seattle-Area Deals News”
Flybridge Unveils Scholarship Program to Help Students Network and Stay in MA
Massachusetts is home to perhaps the world’s greatest concentration of top colleges and universities, many of them rich in the science and engineering education that forms the backbone of our high-tech economy. But one rap the Bay State has taken is that many graduates leave for jobs on the West Coast and other places rather … Continue reading “Flybridge Unveils Scholarship Program to Help Students Network and Stay in MA”
Prostate Cancer Drug Vaults OncoGenex Onto Investor Radar Screens
The best-performing stock on the Nasdaq last week was a little biotech company from the Pacific Northwest that few people had heard of before. The company was OncoGenex Pharmaceuticals, a cancer drug developer based in Vancouver, BC and Bothell, WA, with technology licensed from Carlsbad, CA-based Isis Pharmaceuticals. Before last week, OncoGenex appeared to be … Continue reading “Prostate Cancer Drug Vaults OncoGenex Onto Investor Radar Screens”
BlueKai Makes Splash with $10.5M Round, Wants Advertisers to Understand Consumer Intentions
BlueKai, an online-marketing startup in Bellevue, WA, has nailed down one of the bigger tech venture deals of the past few months. The company is announcing today it has closed a $10.5 million Series B investment led by Battery Ventures, based in Waltham, MA, and Menlo Park, CA. The round also includes returning investor Redpoint … Continue reading “BlueKai Makes Splash with $10.5M Round, Wants Advertisers to Understand Consumer Intentions”
Metabasis CEO Resigns
San Diego’s Metabasis Therapeutics (NASDAQ: [[ticker:MBRX]]) said today that co-founder Paul Laikind has resigned as CEO and interim chief financial officer. The biotech, which is developing drugs for diabetes and liver disease, says Laikind will remain on the company’s board. Mark Erion, a co-founder and chief scientific officer, was named as Laikind’s replacement. In connection with … Continue reading “Metabasis CEO Resigns”
Seventh Sense Biosystems Inc Receives $4,180,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bed7ea6a-aefa-4d64-8745-c8f382dd3c7a&Preview=1 Date 12/16/2008 Company Name Seventh Sense Biosystems Inc Mailing Address One Memorial Drive 7th Floor Cambridge, MA 02142 Company Description Seventh Sense Biosystems Inc is a medical device startup company. Website Undisclosed Transaction Type Venture Equity Transaction Amount $4,180,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A … Continue reading “Seventh Sense Biosystems Inc Receives $4,180,000 Series A Financing Round”
Blue Kai, Inc. Secures $10,500,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8781001c-838d-4984-ba53-1fb6d8ebc3a5&Preview=1 Date 12/16/2008 Company Name Blue Kai, Inc. Mailing Address 170 120th Ave Bellevue, WA 98005 Company Description Blue Kai is developing an online marketplace based on relevant marketing. Website http://www.bluekai.com Transaction Type Venture Equity Transaction Amount $10,500,000 Transaction Round Series B Proceeds Purposes The new funds will be used for “more … Continue reading “Blue Kai, Inc. Secures $10,500,000 Series B Funding Round”
ImageMetrics Secures $6,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=643e546c-c8ad-44ca-a26b-1cdffcc485bb&Preview=1 Date 12/16/2008 Company Name ImageMetrics Mailing Address 1918 Main Street, 2nd Floor Santa Monica, CA 90405 Company Description Image Metrics provides superior facial animation solutions to the entertainment industry. Its mission is to create believable facial performances that emotionally connect audiences to digital characters in films, games and other forms of … Continue reading “ImageMetrics Secures $6,500,000 New Funding Round”
Aravo Solutions Obtains $7,000,000 Series D Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1a7642b5-43a5-4f9c-8311-40a96302de73&Preview=1 Date 12/16/2008 Company Name Aravo Solutions Mailing Address 400 Montgomery Street 10th Floor San Francisco, CA 94104 Company Description Aravo Solutions reduces supply costs for Global 2000 organizations by providing visibility and control over the entire range of supply management business processes from defining commodity strategy and enabling suppliers through managing … Continue reading “Aravo Solutions Obtains $7,000,000 Series D Round”
DotBlu Garners $2,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=db229665-3da2-41cc-b7fa-5312dd669855&Preview=1 Date 12/16/2008 Company Name DotBlu Mailing Address 208 Utah Street San Francisco, CA 94103 Company Description Our members compete in a variety of different online games, like prediction questions, quizzes and online flash games. They compete against friends in a fun and friendly atmosphere for BluBucks, our virtual currency, and use … Continue reading “DotBlu Garners $2,000,000 Series A Financing”
Genzyme Wins FDA Approval of Mozobil
Genzyme won FDA approval today of a new drug for patients with blood cancers. The Cambridge, MA-based biotech company (NASDAQ: [[ticker:GENZ]]) said it has gotten clearance to sell plerixafor (Mozobil) as an injectable drug for patients with a pair of deadly blood malignancies, non-Hodgkin’s lymphoma and multiple myeloma, who need transplants of blood-forming stem cells. … Continue reading “Genzyme Wins FDA Approval of Mozobil”
InFocus Cuts 30 Percent of Staff
Wilsonville, OR-based InFocus (NASDAQ: [[ticker:INFS]]), a maker of digital projectors, announced today it is reducing its global workforce by 30 percent, as part of a company restructuring that will span all of 2009. The staff cuts will be effective next month. InFocus president and CEO Bob O’Malley cited the economic downturn and reduced demand for … Continue reading “InFocus Cuts 30 Percent of Staff”
TransMedics Pulls IPO
TransMedics has nixed plans for an IPO worth up to $86 million, citing unfavorable market conditions. The Andover, MA-based firm, which first filed for the offering in September 2007, develops systems for transporting organs for transplant.
Boston Hedge Fund Lashes Northstar Neuroscience, Urges Liquidation
Pressure is mounting once again on Northstar Neuroscience to fold up its tent and go home. The Seattle-based medical device company got hit today with an angry letter from one of its largest shareholders, Boston-based RA Capital, which urges the board to shut down the company and distribute all of its remaining cash and assets … Continue reading “Boston Hedge Fund Lashes Northstar Neuroscience, Urges Liquidation”